<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7A0397DD-E0C6-4EA3-8031-B841D2503C4D"><gtr:id>7A0397DD-E0C6-4EA3-8031-B841D2503C4D</gtr:id><gtr:name>Royal Holloway, University of London</gtr:name><gtr:address><gtr:line1>Egham Hill</gtr:line1><gtr:line4>Egham</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>TW20 0EX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Wolfson Centre for Age Related Diseases</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7A0397DD-E0C6-4EA3-8031-B841D2503C4D"><gtr:id>7A0397DD-E0C6-4EA3-8031-B841D2503C4D</gtr:id><gtr:name>Royal Holloway, University of London</gtr:name><gtr:address><gtr:line1>Egham Hill</gtr:line1><gtr:line4>Egham</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>TW20 0EX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EA3995C5-A624-4242-835A-E4797A9F6A79"><gtr:id>EA3995C5-A624-4242-835A-E4797A9F6A79</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Brendan</gtr:otherNames><gtr:surname>McMahon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/19859405-0974-48CE-8E15-8C43075F9098"><gtr:id>19859405-0974-48CE-8E15-8C43075F9098</gtr:id><gtr:firstName>Ping</gtr:firstName><gtr:surname>Yip</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0501617"><gtr:id>C37ED9AF-D392-47E5-8C31-A7C0295C4E60</gtr:id><gtr:title>Overexpression of neuronal calcium sensor-1 to promote axonal regeneration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501617</gtr:grantReference><gtr:abstractText>Patients with spinal cord injury (SCI) are often left with severe sensory, motor and autonomic functional deficits. In the proposed research we aim to test the hypothesis that adding a calcium sensor protein; neuronal calcium sensor-1 (NCS-1) can enable adult nerves to regenerate. This small molecule is involved in the growth of axons and formation of synapses (the wiring and communication points of nerves) in the embryonic brain and spinal cord. This molecule is usually only expressed in the embryonic nervous system which, as well as normal growth, is also capable of significant regeneration after injury. We plan to increase the NCS-1 content of injured nerves in two models of SCI in the adult rat. The differences between the two models will allow us to examine the contribution of different mechanisms that may underlie any functional recovery caused by the increase in NCS-1. 
Clinically the treatment of the neuronal injury following SCI is delayed by the need to stabilise the patient, therefore we will test if increasing NCS-1 after as opposed to at the same time as the injury can induce recovery. We hope this work may contribute to new treatment options in SCI.</gtr:abstractText><gtr:technicalSummary>We will test the hypothesis that Neuronal Calcium Sensor-1 (NCS-1, frequenin) promotes regeneration of adult neurones and may be of use in treating spinal cord injury. 
We identified NCS-1 in a microarray screen of spinal cord treated with a pro-regenerative factor. Published work has demonstrated that NCS-1 can induce axonogenesis, synaptogenesis and plasticity in the developing CNS. To date it has not been associated with axonal growth and regeneration in the adult. We aim to overexpress NCS-1 in neurones using a viral vector and assess growth in vitro and in vivo. 
First, we will study adult primary sensory neurones in dissociated cultures and ask if NCS-1 overexpression induces neuritogenesis and neurite outgrowth on permissive and inhibitory substrates. We have pilot data that this is the case. Second, we will study in vivo whether virally overexpressing NCS-1 in the pyramidal neurones of adult rats can promote recovery. Subsequently we will investigate whether this recovery is due to axonal regeneration and/or structural plasticity of unlesioned axons. The work would be carried out in two models of spinal cord injury. Bilateral injury to both descending corticospinal tract (CST) ?dorsal column crush? or unilateral injury to one descending CST ?pyramidotomy?. The former would examine axonal regeneration and the latter structural plasticity. Clinically the treatment of SCI must follow injury. Therefore we will test if delayed overexpression of NCS-1 post-lesion could encourage functional recovery.</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-18</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-06-19</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>327991</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Holloway, University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>lentiviral collaboration</gtr:description><gtr:id>EC451DD0-2D77-4E07-9D65-A566EC5139D0</gtr:id><gtr:impact>None yet</gtr:impact><gtr:partnerContribution>Provided the dual promoter lentiviral vector</gtr:partnerContribution><gtr:piContribution>investigated action of lentiviral vector</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>International meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DC785E35-75D0-4BCB-8290-B03F795C931E</gtr:id><gtr:impact>Presentation of the data regarding NCS1 with spinal cord injury to about 100 paticipants at scientific meeting

None</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>centre meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4FB9389D-2C07-46AD-AC2F-F6DC3C25B102</gtr:id><gtr:impact>Presentation of the data regarding NCS1 with spinal cord injury to 50 internal staff members

none</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Affected scientific technique</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD44CB38-3EEF-446F-952A-36F97384181D</gtr:id><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Created an overexpressing lentiviral vector with dual promoters which allows gene of interest and a reporter gene, eGFP to be simultanously overexpressed in the same transduced neurone.</gtr:description><gtr:id>71C3C597-1680-4961-B21A-00C363AB4CA5</gtr:id><gtr:impact>Improvement on the interpretation of gene therapy using lentivectors both as a therapy and as a tool in the understanding of basis neuronal morphology.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dual promoter lentivector</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/719A7E58-49DA-4127-AA2F-512165B55087"><gtr:id>719A7E58-49DA-4127-AA2F-512165B55087</gtr:id><gtr:title>Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8101ac56478d609f959737145ddff57c"><gtr:id>8101ac56478d609f959737145ddff57c</gtr:id><gtr:otherNames>Kaan TK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7ACD3F5B-F724-41A7-AFCF-557F06675DDC"><gtr:id>7ACD3F5B-F724-41A7-AFCF-557F06675DDC</gtr:id><gtr:title>Endogenous purinergic control of bladder activity via presynaptic P2X3 and P2X2/3 receptors in the spinal cord.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8101ac56478d609f959737145ddff57c"><gtr:id>8101ac56478d609f959737145ddff57c</gtr:id><gtr:otherNames>Kaan TK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7433A042-BC11-46AC-94D7-2F9846338FB6"><gtr:id>7433A042-BC11-46AC-94D7-2F9846338FB6</gtr:id><gtr:title>Cortical overexpression of neuronal calcium sensor-1 induces functional plasticity in spinal cord following unilateral pyramidal tract injury in rat.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/24d2482476a798cc557af102b034ebc7"><gtr:id>24d2482476a798cc557af102b034ebc7</gtr:id><gtr:otherNames>Yip PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501617</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>6393C0B5-F394-4AB6-9626-AD6D94C7BCB5</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Injuries and Accidents</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>